Condition
Choroidal Neovascularization clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Choroidal Neovascularization clinical trials that are recruiting, at sites in 20 countries (most in France (2), Spain (2), United States (2)). By phase: Phase 2/3 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 20Countries
Newest Choroidal Neovascularization clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Tiespectus (MK-8748) versus aflibercept to treat neovascular (wet) age-related macular degeneration | Phase 2/3 | Gilbert, Arizona and 70 other locations | Recruiting | Mar 27, 2026 |
| Comparing tiespectus (MK-8748) with aflibercept for wet age-related macular degeneration | Phase 2/3 | Scottsdale, Arizona and 131 other locations | Recruiting | Feb 27, 2026 |
| Watching a short video before anti-VEGF eye injections | — | Hangzhou, Zhejiang | Recruiting | Jun 3, 2025 |
| Biomarkers for CNV and response to anti-VEGF in eye disease | — | Paris and 1 other locations | Recruiting | Jun 19, 2020 |
All recruiting trials (4)
-
Tiespectus (MK-8748) versus aflibercept to treat neovascular (wet) age-related macular degeneration
The study will see if tiespectus (MK-8748) works as well as aflibercept for people with newly diagnosed neovascular (wet) age-related macular degeneration.
-
Comparing tiespectus (MK-8748) with aflibercept for wet age-related macular degeneration
This study will test whether tiespectus (MK-8748) works as well as aflibercept for people with newly diagnosed neovascular (wet) age-related macular degeneration.
-
Watching a short video before anti-VEGF eye injections
This trial will test whether watching a brief procedural video before a first anti-VEGF intravitreal injection helps people with retinal diseases feel less anxious and have fewer or smaller subconjunctival hemorrhages.
-
Biomarkers for CNV and response to anti-VEGF in eye disease
This study tests blood and eye fluid biomarkers to see if they predict how people with type 1 choroidal neovascularization respond to anti-VEGF therapy.
Related topics
Quick answers
How many Choroidal Neovascularization clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 20 countries. The most sites are in France (2 trials), Spain (2 trials), United States (2 trials), Brazil (1 trial), Colombia (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2/3: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.